BETIMOL Trademark

Trademark Overview

On Friday, February 15, 2013, a trademark application was filed for BETIMOL with the United States Patent and Trademark Office. The USPTO has given the BETIMOL trademark a serial number of 79128616. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, January 22, 2024. This trademark is owned by SANTEN PHARMACEUTICAL CO., LTD.. The BETIMOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of eye diseases and conditions
betimol

General Information

Serial Number79128616
Word MarkBETIMOL
Filing DateFriday, February 15, 2013
Status706 - SECTION 71 ACCEPTED
Status DateMonday, January 22, 2024
Registration Number4442019
Registration DateTuesday, December 3, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of eye diseases and conditions
Translation of Words in MarkThe wording "BETIMOL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 29, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThea Pharma Inc.
Party Type34 - New Owner After Registration
Legal Entity Type99 - Other
AddressWaltham, MA 02451
Party NameAkorn Operating Company LLC
Party Type33 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS
Party NameAkorn International S.à.r.l.
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressL-2540 Luxembourg
LU
Party NameOAK PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJP

Trademark Events

Event DateEvent Description
Wednesday, March 20, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 22, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, January 22, 2024REGISTERED-SEC.71 ACCEPTED
Friday, January 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 9, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 12, 2023TEAS SECTION 71 RECEIVED
Saturday, December 3, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, August 5, 2022CHANGE OF OWNER RECEIVED FROM IB
Friday, December 31, 2021CHANGE OF OWNER RECEIVED FROM IB
Thursday, February 20, 2020INTERNATIONAL REGISTRATION RENEWED
Wednesday, February 27, 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Wednesday, February 27, 2019REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, January 24, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 12, 2018TEAS SECTION 71 & 15 RECEIVED
Monday, December 3, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, December 18, 2014CHANGE OF OWNER RECEIVED FROM IB
Thursday, September 11, 2014CHANGE OF OWNER RECEIVED FROM IB
Friday, March 21, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 6, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 6, 2014FINAL DISPOSITION PROCESSED
Monday, March 3, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 3, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2013PUBLISHED FOR OPPOSITION
Saturday, September 14, 2013NOTIFICATION PROCESSED BY IB
Wednesday, August 28, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 28, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 28, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 11, 2013ASSIGNED TO LIE
Tuesday, July 9, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 30, 2013REFUSAL PROCESSED BY IB
Tuesday, June 11, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 11, 2013REFUSAL PROCESSED BY MPU
Tuesday, June 11, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 10, 2013NON-FINAL ACTION WRITTEN
Saturday, June 1, 2013ASSIGNED TO EXAMINER
Friday, May 3, 2013APPLICATION FILING RECEIPT MAILED
Monday, April 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 26, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 25, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

betimol conditions diseases treatment preparations pharmaceutical